Emory University: clinical-trial pipeline
Emory University is the sponsor of 1,403 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 274 are not yet finished and 14 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials274
Phase 2/3 and 358
Countries41
New in 90 days14
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 820 |
| Phase 2 | 204 |
| Phase 4 | 153 |
| Phase 1 | 116 |
| Phase 3 | 45 |
| Phase 1/2 | 27 |
| Early phase 1 | 25 |
| Phase 2/3 | 13 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 862 |
| Recruiting | 199 |
| Terminated | 174 |
| Withdrawn or not authorised | 76 |
| Active, not recruiting | 42 |
| Not yet recruiting | 33 |
| Unknown | 10 |
| Suspended or halted | 7 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 314 |
| Cardiovascular | 209 |
| Infectious disease and vaccines | 170 |
| Metabolic and endocrine (diabetes, obesity) | 142 |
| Psychiatry and mental health | 123 |
| Rare and genetic diseases | 112 |
| Neurology | 99 |
| Nephrology and urology | 93 |
| Gastroenterology and liver | 65 |
| Respiratory | 57 |
| Haematology | 52 |
| Musculoskeletal | 47 |
Countries
| Country | Trials |
|---|---|
| United States | 1,293 |
| India | 10 |
| Canada | 6 |
| South Africa | 6 |
| Guatemala | 5 |
| Germany | 4 |
| Kenya | 4 |
| China | 3 |
| Ethiopia | 3 |
| Mali | 3 |
| Vietnam | 3 |
| Zambia | 3 |
| Armenia | 2 |
| Spain | 2 |
| United Kingdom | 2 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-19 | New trial posted | Unmasking Diabetes in Dialysis With Continuous Glucose Monitoring |
| 2026-10-07 | New trial posted | US/PA/E Imaging for Early Identification of Tumor Response in Patients With Stage II-III… |
| 2026-10-06 | New trial posted | CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Canc… |
| 2026-10-06 | New trial posted | Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant P… |
| 2026-10-05 | New trial posted | Evaluating the Feasibility of Collecting User Interaction Data at the Emory Autism Center… |
| 2026-09-23 | New trial posted | PFAS Clinical Trial |
| 2026-09-23 | New trial posted | Virtual Outreach and Individualized Coaching Extension |
| 2026-09-17 | New trial posted | Fall Prevention Pathways |
| 2026-09-17 | New trial posted | Diabetes Prevention AI: Enhancing Prevention Strategies Using Personalized Nutrition and… |
| 2026-09-17 | New trial posted | The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation |
| 2026-09-17 | New trial posted | Adaptango Performance PRocess for Older Adults Community reHabilitation |
| 2026-09-16 | New trial posted | Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT04023019 | Treatment of Hemophilia A Patients With FVIII Inhibitors | Not applicable | Recruiting | Bulgaria, Germany, Spain, Finland +4 |
| NCT07859722 | CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer | Not applicable | Not yet recruiting | United States |
| NCT04404530 | Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU) | Not applicable | Recruiting | United States |
| NCT07194083 | Effectiveness- Implementation Trial of the Function-Based Elopement Treatment | Not applicable | Recruiting | United States |
| NCT06492954 | Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosar… | Phase 1 | Recruiting | United States |
| NCT05387915 | Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Po… | Phase 2 | Active, not recruiting | United States |
| NCT07411859 | Reboot Pain (tDCS) | Not applicable | Recruiting | United States |
| NCT05823532 | Anti-Inflammatory Challenge in Schizophrenia | Phase 4 | Recruiting | United States |
| NCT07176988 | Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes | Not applicable | Recruiting | United States |
| NCT06799494 | HPV Vaccine Reduced Dose | Phase 4 | Recruiting | United States |
| NCT06722027 | CCSH (Compassion-Centered Spiritual Health) for Teams | Not applicable | Recruiting | United States |
| NCT03756896 | Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With High-Risk Multiple Myeloma | Phase 2 | Active, not recruiting | United States |
| NCT06254911 | Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma | Phase 2 | Recruiting | United States |
| NCT05928936 | Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD | Phase 2 | Recruiting | United States |
| NCT04848519 | Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma | Phase 2 | Active, not recruiting | United States |
| NCT06914999 | Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluat… | Early phase 1 | Recruiting | United States |
| NCT04780477 | Fiber-rich Foods to Treat Obesity and Prevent Colon Cancer | Not applicable | Active, not recruiting | United States |
| NCT05616546 | Bone Marrow and Peripheral Blood Immune Responses Study | Phase 4 | Recruiting | United States |
| NCT02604277 | Suicidal Behavior in Patients Diagnosed With Bipolar Disorder | Not applicable | Recruiting | United States |
| NCT06636734 | Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer,… | Phase 2 | Recruiting | United States |
| NCT06760507 | Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screeni… | Not applicable | Recruiting | United States |
| NCT07155317 | Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial | Phase 2 | Recruiting | United States |
| NCT04762199 | MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer | Phase 1 | Recruiting | United States |
| NCT02947750 | Neurovascular Transduction During Exercise in Chronic Kidney Disease | Phase 2 | Recruiting | United States |
| NCT06443541 | Strategies for Implementing GlobalConsent to Prevent Sexual Violence in University Men | Not applicable | Recruiting | Vietnam |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Emory University clinical trials: 274 open, 58 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/emory-university/, data as of 2026-10-25.